Report Detail

Request for Sample of this report

Pharma & Healthcare Global Implantable Ophthalmic Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4718812
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 96 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Implantable Ophthalmic Drugs market size was valued at US$ 1559 million in 2025 and is forecast to a readjusted size of US$ 2169 million by 2032 with a CAGR of 4.9% during review period.
Ophthalmic implantable drugs are an innovative technology in the field of ophthalmic treatment in recent years. They deliver drugs directly to the eyes through implanted drug delivery systems, thereby improving the efficiency of the drugs and reducing the patient's medication burden.
This report is a detailed and comprehensive analysis for global Implantable Ophthalmic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Implantable Ophthalmic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Implantable Ophthalmic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Implantable Ophthalmic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Implantable Ophthalmic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Implantable Ophthalmic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Implantable Ophthalmic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan (Durysta, Ozurdex), Glaukos (Idose TR), Graybug Vision (OTX-ITC), Ocular Therapeutix (ReSure), Novartis (Visudyne), Eylea (Bayer, Regeneron), Bausch&Lomb (Retisert, Vitrasert), Alimera Sciences (Iluvien), Mati (Evolute), Roche (Vabysmo), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Implantable Ophthalmic Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vitreous Implant Type
Lacrimal Gland Implant Type
Micropump implantable type
Others
Market segment by Application
Hospital
Clinic
Home
Major players covered
Allergan (Durysta, Ozurdex)
Glaukos (Idose TR)
Graybug Vision (OTX-ITC)
Ocular Therapeutix (ReSure)
Novartis (Visudyne)
Eylea (Bayer, Regeneron)
Bausch&Lomb (Retisert, Vitrasert)
Alimera Sciences (Iluvien)
Mati (Evolute)
Roche (Vabysmo)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Implantable Ophthalmic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implantable Ophthalmic Drugs, with price, sales quantity, revenue, and global market share of Implantable Ophthalmic Drugs from 2021 to 2026.
Chapter 3, the Implantable Ophthalmic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Ophthalmic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Implantable Ophthalmic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Ophthalmic Drugs.
Chapter 14 and 15, to describe Implantable Ophthalmic Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Implantable Ophthalmic Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Vitreous Implant Type
    • 1.3.3 Lacrimal Gland Implant Type
    • 1.3.4 Micropump implantable type
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Implantable Ophthalmic Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Home
  • 1.5 Global Implantable Ophthalmic Drugs Market Size & Forecast
    • 1.5.1 Global Implantable Ophthalmic Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Implantable Ophthalmic Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Implantable Ophthalmic Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Allergan (Durysta, Ozurdex)
    • 2.1.1 Allergan (Durysta, Ozurdex) Details
    • 2.1.2 Allergan (Durysta, Ozurdex) Major Business
    • 2.1.3 Allergan (Durysta, Ozurdex) Implantable Ophthalmic Drugs Product and Services
    • 2.1.4 Allergan (Durysta, Ozurdex) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Allergan (Durysta, Ozurdex) Recent Developments/Updates
  • 2.2 Glaukos (Idose TR)
    • 2.2.1 Glaukos (Idose TR) Details
    • 2.2.2 Glaukos (Idose TR) Major Business
    • 2.2.3 Glaukos (Idose TR) Implantable Ophthalmic Drugs Product and Services
    • 2.2.4 Glaukos (Idose TR) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Glaukos (Idose TR) Recent Developments/Updates
  • 2.3 Graybug Vision (OTX-ITC)
    • 2.3.1 Graybug Vision (OTX-ITC) Details
    • 2.3.2 Graybug Vision (OTX-ITC) Major Business
    • 2.3.3 Graybug Vision (OTX-ITC) Implantable Ophthalmic Drugs Product and Services
    • 2.3.4 Graybug Vision (OTX-ITC) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Graybug Vision (OTX-ITC) Recent Developments/Updates
  • 2.4 Ocular Therapeutix (ReSure)
    • 2.4.1 Ocular Therapeutix (ReSure) Details
    • 2.4.2 Ocular Therapeutix (ReSure) Major Business
    • 2.4.3 Ocular Therapeutix (ReSure) Implantable Ophthalmic Drugs Product and Services
    • 2.4.4 Ocular Therapeutix (ReSure) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ocular Therapeutix (ReSure) Recent Developments/Updates
  • 2.5 Novartis (Visudyne)
    • 2.5.1 Novartis (Visudyne) Details
    • 2.5.2 Novartis (Visudyne) Major Business
    • 2.5.3 Novartis (Visudyne) Implantable Ophthalmic Drugs Product and Services
    • 2.5.4 Novartis (Visudyne) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis (Visudyne) Recent Developments/Updates
  • 2.6 Eylea (Bayer, Regeneron)
    • 2.6.1 Eylea (Bayer, Regeneron) Details
    • 2.6.2 Eylea (Bayer, Regeneron) Major Business
    • 2.6.3 Eylea (Bayer, Regeneron) Implantable Ophthalmic Drugs Product and Services
    • 2.6.4 Eylea (Bayer, Regeneron) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eylea (Bayer, Regeneron) Recent Developments/Updates
  • 2.7 Bausch&Lomb (Retisert, Vitrasert)
    • 2.7.1 Bausch&Lomb (Retisert, Vitrasert) Details
    • 2.7.2 Bausch&Lomb (Retisert, Vitrasert) Major Business
    • 2.7.3 Bausch&Lomb (Retisert, Vitrasert) Implantable Ophthalmic Drugs Product and Services
    • 2.7.4 Bausch&Lomb (Retisert, Vitrasert) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bausch&Lomb (Retisert, Vitrasert) Recent Developments/Updates
  • 2.8 Alimera Sciences (Iluvien)
    • 2.8.1 Alimera Sciences (Iluvien) Details
    • 2.8.2 Alimera Sciences (Iluvien) Major Business
    • 2.8.3 Alimera Sciences (Iluvien) Implantable Ophthalmic Drugs Product and Services
    • 2.8.4 Alimera Sciences (Iluvien) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Alimera Sciences (Iluvien) Recent Developments/Updates
  • 2.9 Mati (Evolute)
    • 2.9.1 Mati (Evolute) Details
    • 2.9.2 Mati (Evolute) Major Business
    • 2.9.3 Mati (Evolute) Implantable Ophthalmic Drugs Product and Services
    • 2.9.4 Mati (Evolute) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mati (Evolute) Recent Developments/Updates
  • 2.10 Roche (Vabysmo)
    • 2.10.1 Roche (Vabysmo) Details
    • 2.10.2 Roche (Vabysmo) Major Business
    • 2.10.3 Roche (Vabysmo) Implantable Ophthalmic Drugs Product and Services
    • 2.10.4 Roche (Vabysmo) Implantable Ophthalmic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Roche (Vabysmo) Recent Developments/Updates

3 Competitive Environment: Implantable Ophthalmic Drugs by Manufacturer

  • 3.1 Global Implantable Ophthalmic Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Implantable Ophthalmic Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Implantable Ophthalmic Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Implantable Ophthalmic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Implantable Ophthalmic Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Implantable Ophthalmic Drugs Manufacturer Market Share in 2025
  • 3.5 Implantable Ophthalmic Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Implantable Ophthalmic Drugs Market: Region Footprint
    • 3.5.2 Implantable Ophthalmic Drugs Market: Company Product Type Footprint
    • 3.5.3 Implantable Ophthalmic Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Implantable Ophthalmic Drugs Market Size by Region
    • 4.1.1 Global Implantable Ophthalmic Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Implantable Ophthalmic Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Implantable Ophthalmic Drugs Average Price by Region (2021-2032)
  • 4.2 North America Implantable Ophthalmic Drugs Consumption Value (2021-2032)
  • 4.3 Europe Implantable Ophthalmic Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Implantable Ophthalmic Drugs Consumption Value (2021-2032)
  • 4.5 South America Implantable Ophthalmic Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Implantable Ophthalmic Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Implantable Ophthalmic Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Implantable Ophthalmic Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Implantable Ophthalmic Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Implantable Ophthalmic Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Implantable Ophthalmic Drugs Market Size by Country
    • 7.3.1 North America Implantable Ophthalmic Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Implantable Ophthalmic Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Implantable Ophthalmic Drugs Market Size by Country
    • 8.3.1 Europe Implantable Ophthalmic Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Implantable Ophthalmic Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Implantable Ophthalmic Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Implantable Ophthalmic Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Implantable Ophthalmic Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Implantable Ophthalmic Drugs Market Size by Country
    • 10.3.1 South America Implantable Ophthalmic Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Implantable Ophthalmic Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Implantable Ophthalmic Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Implantable Ophthalmic Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Implantable Ophthalmic Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Implantable Ophthalmic Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Implantable Ophthalmic Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Implantable Ophthalmic Drugs Market Drivers
  • 12.2 Implantable Ophthalmic Drugs Market Restraints
  • 12.3 Implantable Ophthalmic Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Implantable Ophthalmic Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Implantable Ophthalmic Drugs
  • 13.3 Implantable Ophthalmic Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Implantable Ophthalmic Drugs Typical Distributors
  • 14.3 Implantable Ophthalmic Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Implantable Ophthalmic Drugs. Industry analysis & Market Report on Implantable Ophthalmic Drugs is a syndicated market report, published as Global Implantable Ophthalmic Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Implantable Ophthalmic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo